A whole system of people. A place for your organisation.
Explore the full intended PHARMORIS scope—from trusts, health boards and GP practices to pharmacies, care services, commissioners, industry and the people receiving care.
In development · Intended scope and questions for evaluation
One programme.
A whole system of people.
Choose an organisation. See its role, the decisions it owns and the people it depends on.
medicines
programme
Trusts & health boards
Clinical services, pharmacy operations and finance each bring a different part of the delivery case.
- The decision
- Which medicines programme is appropriate, deliverable and worth evaluating in this service?
- The dependencies
- Specialist teams, general practice, community pharmacy, procurement, commissioners, digital and information-governance colleagues.
- What to examine
- Clinical applicability, staff capacity, implementation effort, continuity of care and full programme cost.
An illustrative map of intended scope. Each organisation keeps its own authority and permissions. Connections describe possible programme relationships; they do not establish customers, integrations or shared access to information.
Find your place
in the programme.
Different organisations. Different responsibilities. A connected set of questions about evidence, resources, delivery and value.
Trusts & health boards
Clinical services, pharmacy operations and finance each bring a different part of the delivery case.
02GP practices & PCNs
A useful medicines programme has to fit the practice day, the clinical team and the people receiving care.
03Community pharmacies
The owner, pharmacist and pharmacy team need a programme that makes sense at the counter and in the business.
04Pharmacy groups & online providers
A programme that works in one branch still has to earn its place across a network.
05Commissioners & payers
A system-level opportunity needs a clear account of who does the work, who pays and when value could appear.
06Care homes, community & homecare
Medicines programmes cross places of care. Responsibility and practical follow-through need to travel with them.
07Manufacturers & pharmaceutical businesses
Evidence, supply and implementation shape whether a medicines proposition can become useful in a receiving service.
08Wholesalers & distributors
Availability, handling and the work of resolving an exception affect the organisations waiting for medicines.
09Clinical, operational & finance teams
One programme carries several decisions. Its clinical case, staffing plan and financial case need different accountable reviewers.
10Patients, carers & communities
The people receiving care are affected by the design of a medicines service and deserve a meaningful place in its evaluation.
11Research & evaluation partners
The product has to earn confidence through a comparison that includes the whole job and can expose failure.
12International health systems & payers
The same broad programme questions meet different authorities, funding arrangements and evidence in each health system.
12 organisation perspectives
Bring the question
your organisation
needs to move.
Tell us where the programme gets stuck, who is affected and what a worthwhile evaluation would help you decide.
Discuss a PHARMORIS evaluationAn initial conversation should describe the organisational question. Agree the purpose and information requirements before sharing records.